News about Immunotherapy

Researchers identify three conditions that could increase mortality due to neurological complications derived from a type of cancer immunotherapy

Immune checkpoint inhibitors are a type of immunotherapy against cancer that activates the immune system to attack tumour cells. Although it is quite1

Clínic Barcelona

Research January 27 2023

IDIBAPS establishes a new research group devoted to cellular immunotherapies aimed at combatting cancer

The IDIBAPS Board of Governors has approved the creation of a new research group. The decision follows the scientific evaluation of the researchers –1

Clínic Barcelona

Institutional September 22 2022

The Hospital Clínic starts an immunotherapy trial based on tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer

Trial TILs001, which is open to patients with metastatic triple-negative breast cancer, is the first study to assess the safety and efficacy of TILs1

News about Immunotherapy

Researchers identify three conditions that could increase mortality due to neurological complications derived from a type of cancer immunotherapy

IDIBAPS establishes a new research group devoted to cellular immunotherapies aimed at combatting cancer

The Hospital Clínic starts an immunotherapy trial based on tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer

Subscribe to the Newsletter of Clínic